Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Novavax, Inc. - Common Stock (NQ:NVAX)

6.050 +0.080 (+1.34%)
Streaming Delayed Price Updated: 11:57 AM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
62 63 Next >
What's Going On With Novavax Stock Today?
Novavax Inc (NASDAQ: NVAX) shares are trading higher Monday after the company announced a CEO transition. 
Via Benzinga
Is Novavax Stock a Bargain After Falling More Than 90% From Its High?
Could the biotech be the ultimate contrarian buy of 2023? 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
How 'Covid Darling' Pfizer Became A 'Show Me' Story For 2023
Sales of Paxlovid and Comirnaty are expected to continue declining this year and next. 
Via Investor's Business Daily
Analyzing Novavax's Short Interest
Novavax's (NASDAQ:NVAX) short percent of float has fallen 4.15% since its last report. The company recently reported that it has 24.47 million shares sold short, which is 28.87% of all regular shares... 
Via Benzinga
US Stocks On Track To Start 2023 On Upbeat Note: Investors Shrug Off Past Year's Dismal Show And Pin Hopes On A Rebound
Trading in the U.S. index futures suggests that stocks may get off to a strong start in the first trading session of 2023. The mood is in contrast to the cautious outlook given by most Wall Street... 
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for Novavax: Here's What You Need To Know
Via Benzinga
Better Recovery Story Buy: Teladoc vs. Novavax
These stocks each sank more than 70% this year. 
Via The Motley Fool
7 Sensational Stocks That Can Double Your Money in 2023
Triple-digit returns could be just a click away from the buy button. 
Via The Motley Fool
What You Missed On Wall Street On Friday
In the midst of markets falling, some companies had good news, while others took a hit from analysts and a merger is still on hold. 
Via Talk Markets
2 Growth Stocks to Buy Heading Into 2023
These biotechs are far from having achieved their full potential. 
Via The Motley Fool
Novavax Kickstarts Phase 2 Trial For COVID-19-Flu Combo, Stand-Alone Flu Vaccine Candidates
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Is There Any Hope for Novavax?
The near term looks complicated for this biotech player. 
Via The Motley Fool
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. 
Via Benzinga
Got $1,000? 5 Sensational Stocks to Buy to Start 2023 With a Bang
You don't need a mountain of money to grow your wealth on Wall Street. 
Via The Motley Fool
Three Pharma Stocks to Sell Before They Die
As we head into New Year 2023, these are just some of the top pharma stocks to sell at the start of January. 
Via InvestorPlace
The Best And Worst Performing Stocks Of 2022 (Through 12/22)
A look at the best and worst performing Russell 1,000 stocks year-to-date on a total return basis. 
Via Talk Markets
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. 
Via Benzinga
Why Is Agrify (AGFY) Stock Down 50% Today?
Agrify (AGFY) stock is on the move Friday as the company's shares take a beating after revealing details of a stock offering. 
Via InvestorPlace
Why Is Novavax (NVAX) Stock Down 10% Today?
Novavax is conducting a public offering of 6.5 million shares. Here's why the news is pushing NVAX stock down. 
Via InvestorPlace
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results. 
Via Benzinga
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
2 Biotech Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
Two drug developers stand out as plain-as-day bargains in the new year, while another top-performing biotech stock looks poised to disappoint. 
Via The Motley Fool
Novavax To See More Downside After Thursday's 34% Plunge? Vaccine Maker Prices Stock Offering At 13% Discount
Shares of Maryland-based coronavirus vaccine manufacturer Novavax Inc. 
Via Benzinga
Tesla, Apple, Novavax, Adobe, Guardant Health: Why These 5 Stocks Are Drawing Investors' Attention Today
Major Wall Street indices closed over 2% lower on Thursday after U.S. retail sales saw their steepest drop in close to a year last month, suggesting consumers are reining in spending around the... 
Via Benzinga
These 2 Small-Cap Stocks Fell Hard Thursday
Even in a down market, the extent of these drops was severe. 
Via The Motley Fool
Dow Dips Over 800 Points; S&P 500 Down 2.8%
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 800 points. 
Via Benzinga
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
62 63 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.